Critical Implications of EU AI Act For Healthcare Communications: What It Means for Pharma

While the regulation is focused on EU audiences, its impact may extend to global healthcare organizations that create or distribute AI-enabled content in Europe or are EU-based. These transparency requirements can apply to both EU and non-EU organizations when AI-generated or AI-assisted content is intended for, distributed to, or used by audiences in the EU. For healthcare organizations, the critical consideration is not just where the content was created, but whether it is being deployed to reach EU audiences.

Transparency is becoming a communications issue, not just a compliance issue

AI disclosure may once have been viewed primarily as a legal or technical consideration, but Article 50 signals that audiences will increasingly expect to know when they are engaging with AI-generated, AI-assisted, or AI-mediated content unless it is obvious from the point of view of someone reasonably well-informed. For healthcare organizations, that transparency is critical to stakeholder credibility and trust. Additionally, the EU will levy significant fines for violations of the Act.

AI usage tracking and human oversight matter

This aspect of the trust equation is more than a simple quality-control step. Organizations must track their use of AI throughout the process and be able to demonstrate meaningful human review and accountability for any content that incorporates AI. Medical Writer, dual human reviews of medical content becomes a compliance requirement.

Planning early is critical

Transparency of this degree cannot be added at the end of the creative process. Teams should identify the use of AI during planning, content development, and review workflows rather than at launch.

Mandatory staff training – AI literacy

The EU AI Act legally requires all organizations deploying AI to ensure their teams possess adequate “AI Literacy,” and understand what they need to disclose when using AI.

Annual Training

All employees must complete internal AI Training modules covering data security, bias identification, and prompt engineering safety.

Log Everything

Teams must keep a brief record of the AI tools used during the creation of any campaign to ensure full traceability in the event of a regulatory audit.

What Actions Should We Take to Stay Compliant with Article 50

Action Item

For any public-facing AI asset, Spectrum can partner with companies to determine the appropriate disclosure language and best recommendation based on their legal and regulatory approval requirements.

Digital Experience & Patient Engagement

For websites, chatbots, virtual assistants, and support programs, transparency should occur early in the interaction, users should understand when AI is involved and escalation paths to human support should remain clear when appropriate. With chatbot transparency, patients must know exactly who or what they are talking to.

No Subliminal Manipulation

Adherence or patient support programs must not use AI to subtly “nudge” patient behavior in a way that could cause mental or physical distress.

No Emotion Recognition

It is not permitted to use AI tools that claim to analyze or track a patient’s mood, emotional state, or facial expressions. This is strictly prohibited under the EU AI Act in key environments.

Advertising

Under the EU AI Act, transparency is a legal mandate for Advertising. Advertising audiences are generally accustomed to disclosures, disclaimers, and required labeling. In many situations, transparency language can be incorporated into existing disclosure frameworks with limited impact on the user experience. Ghost writing marketing content is prohibited without clear disclosure. No AI-generated clinical statement may be included in external materials without dual-human verification against primary source documents (e.g., clinical trial reports, approved SmPCs).

Communications & Corporate Affairs

This area will likely require more thoughtful implementation as communications content often relies on editorial flow and audience engagement. Simply inserting disclosure language may disrupt storytelling or undermine readability if not handled strategically.

Social Media

When it comes to social media, the important wording for healthcare is “matters of public interest.” The AI Act specifically requires disclosure where AI-generated or manipulated text is published for the purpose of informing the public about matters of public interest, unless there has been human review and the publisher has editorial responsibility. Healthcare is a particularly obvious area where a social media post can be a matter of public interest. AI-generated visuals, captions, and campaign assets may require added scrutiny because social content is often shared quickly, consumed with limited context, and aimed at a global audience. Teams should consider whether disclosure is needed at the post, campaign, or channel level, especially for global programs where audience reach may trigger different market-specific expectations.

Momentum Takeaways

What we’re seeing is that Article 50 is a fundamental shift toward transparency and trust in AI-enabled communications. Organizations that establish thoughtful governance and disclosure practices now will be compliance expectations which will continue to evolve. This is particularly important in healthcare communications, where credibility plays a critical role in decision-making and engagement around sensitive subject matter.

At Spectrum Science, we’re actively monitoring how Article 50 evolves and helping clients build communications strategies that are both compliant and credible. If you’re wondering what this means for your next campaign, let’s talk.